It has been demonstrated that BRCA1 deficiency drives metabolic reprogramming by upregulating nicotinamide N-methyltransferase (NNMT), sensitizing ovarian cancer cells to agents that inhibit energy metabolism [104]. The gene discussed is BRCA1; the disease is ovarian cancer.